Myriad Genetics, Inc.: Myriad Genetics Expands Availability of Precise MRD for Colorectal, Renal and Breast Cancers, Supported by New Publication

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise ...
Neuroscience News

Study Supports and Expands the Primate Brain Lag Hypothesis

Summary: A new study has completely revived and expanded this lost chapter of human evolution. Leveraging modern molecular genetic dating and advanced phylogenetic statistical modeling, researchers ...
Phys.org

Beyond Mendel: Researchers call for a new understanding of genetics

For more than a century, Mendelian genetics has shaped how we think about inheritance: one gene, one trait. It is a model that still echoes through textbooks—and one that is increasingly reaching its ...
Labroots

Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026

Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026 held on May 13th, 2026! The Precision Medicine: Genomics, ...
ascopubs.org

Molecular profiling of head and neck cancers (HNCs): Genetic heterogeneity, immune landscape, and therapeutic targets.

Predictive value of TTMV HPV DNA kinetics in induction chemotherapy in HPV-positive head and neck squamous cell carcinoma. ESCAT TIER distribution of the molecular alterations detected in head and ...

Synthetic DNA toolkit expands scientists' ability to recognize genetic targets

A new method for recognizing and targeting DNA that dramatically expands the range of genetic sequences scientists can identify has been developed by experts at the University of Portsmouth. Published ...